EPR Biotech News

July 10th 2010
Categories: Biochemicals, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Healthcare, Medicine, Pharmaceuticals, Science

No Comments

Scientist Uses Stem Cells To Repair Heart

Dr. Joshua Hare believes medicine is close to a goal long thought to be impossible: healing the human heart. The way to get there? Stem cells. "These could be as big as antibiotics were in the last century," said Hare, who leads the University of Miami 's new Stem Cell Institute. "Stem ...
July 10th 2010
Categories: Biochemicals, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Healthcare, Medicine, Pharmaceuticals, Science

No Comments

Now, Women Can Bank On ‘Monthly Miracle’ For Future Treatment

Women in the city will soon have the option of banking their menstrual blood so that menstrual blood stem cells can be used for treatment of serious disorders through stem cell therapy. In six months, Life Cell International, in technology partnership with Cryo-Cell International, will set up the facility, which will be ...

Pages

 

February 2012
M T W T F S S
« Jan    
 12345
6789101112
13141516171819
20212223242526
272829  

Advertisements

Categories

Recent Posts

Tags

Blogroll

Archives

Meta

January 25th 2012
Tags: Biomedical Engineering, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Genetics, Pharmaceuticals No Comments

Advinus, SignalChem Start The Multi-Year, Multi-Target Collaboration On New Anti-Cancer Drugs

Advinus Therapeutics, a research-based pharmaceutical development company promoted by the TATA Group, and SignalChem Pharmaceuticals, a British Columbia-based drug discovery company, have started working on 15 programs based on SignalChem’s proprietary Kinase platform for targeted therapies in oncology. Each program is being developed with corresponding diagnostics and tracers for patient ...
November 24th 2011
Tags: Biomedical Engineering, Biopharmaceutical, Biotech, Biotech Products, Biotech Services, Biotech Solutions, Biotechnology, Genetics, Pharmaceuticals No Comments

CYTOO Raises 10 M$ (7M€) in Series C Round

CYTOO SA, a company that specializes in cell-based assays, is pleased to announce the closing of a series C funding round of USD 10M (EUR 7M). New investors, Sham and Entrepreneurs Fund (EF), led the round. Existing investors AURIGA Partners and Jacques Lewiner, co-founder and president of the supervisory board ...

Search

The archives run deep. Feel free to search older content using topic keywords.